Markus et al. have also reported potential cardioembolic stroke biomarkers in their study, including common inflammatory markers CRP, interleukin-6, interleukin-1β, and tumor necrosis factor-α [24], whereas, currently, there were no specific and highly sensitive biomarkers for distinguishing CS from large stroke cases. This evidence concerns the gene TNF and stroke disorder.